AUTHOREA
Log in Sign Up Browse Preprints
LOG IN SIGN UP
Paula Molina
Paula Molina

Public Documents 2
Novel mutation c.1224_1225insGTCC (p.Cys409Valfs*41) of MEN1 gene in a multiple endoc...
Paula Molina
Ernesto Ruiz

Paula Molina

and 3 more

June 22, 2020
Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder with tumor predisposition in the parathyroid gland, anterior hypophysis and pancreatic islet cells. Here we describe the first Costa Rican MEN1 case with a novel MEN1 mutation in a 37-year-old male with history of nephrolithiasis and recurrent hypoglycemia
Novel mutation c.1224_1225insGTCC (p.Cys409Valfs*41) of MEN1 gene in a multiple endoc...
Paula Molina
Ernesto Ruiz

Paula Molina

and 3 more

May 18, 2020
Abstract Multiple endocrine neoplasia type 1 (MEN1) is a rare autosomal dominant disorder characterized by a predisposition for tumors in the parathyroid gland, anterior hypophysis and pancreatic islet cells. Here we describe the first Costa Rican MEN1 case with a novel MEN1 mutation in a 37-year-old male with history of nephrolithiasis and recurrent hypoglycemic episodes. Initial laboratories revealed hypoglycemia and primary hyperparathyroidism. A fasting test was positive at three hours demonstrating hyperinsulinemic hypoglycemia. An abdominal CT SCAN showed one mass in the pancreatic tail and bilateral nephrolithiasis. Direct sequence analysis of MEN1 gene revealed heterozygosity for a novel pathogenic insertion c.1224_1225insGTCC (p.Cys409Valfs*41). Early genetic diagnosis of MEN1 could identify individuals in a presymptomatic stage of the disease which could introduce them in periodic surveillance programs for early identification and treatment of associated tumors. Key words Multiple endocrine neoplasia, primary hyperparathyroidism, insulinoma, hypoglycemia, nephrolithiasis

| Powered by Authorea.com

  • Home